Literature DB >> 6617712

Close correlation of acetaminophen clearance with that of conjugated benzodiazepines but not oxidized benzodiazepines.

D J Greenblatt, D R Abernethy, M Divoll, R I Shader.   

Abstract

The clearance of the antipyretic-analgesic drug acetaminophen, biotransformed in humans by glucuronide and sulfate conjugation, was evaluated in 32 healthy young and elderly volunteers. Subjects received a single 650-mg dose of acetaminophen, and multiple plasma concentrations measured over the next 12 h. Random subgroups of subjects also participated in studies of the oxidized benzodiazepines diazepam, desmethyldiazepam and alprazolam, and of the conjugated benzodiazepines lorazepam, oxazepam and temazepam. Acetaminophen clearance was not related to that of the oxidized benzodiazepines, but was highly correlated with clearance of lorazepam (r = 0.70, n = 11, p less than 0.02), oxazepam (r = 0.76, n = 14, p less than 0.005) and temazepam (r = 0.63, n = 16, p less than 0.01). Thus acetaminophen may serve as a probe or marker compound to evaluate drug conjugating capacity in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617712     DOI: 10.1007/bf00544026

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

Review 2.  Factors influencing antipyrine elimination.

Authors:  I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

4.  Lorazepam kinetics in the elderly.

Authors:  D J Greenblatt; M D Allen; A Locniskar; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

5.  Effect of age and gender on disposition of temazepam.

Authors:  M Divoll; D J Greenblatt; J S Harmatz; R I Shader
Journal:  J Pharm Sci       Date:  1981-10       Impact factor: 3.534

6.  Oxazepam kinetics: effects of age and sex.

Authors:  D J Greenblatt; M Divoll; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

7.  Diazepam disposition determinants.

Authors:  D J Greenblatt; M D Allen; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

8.  Alprazolam kinetics in the elderly. Relation to antipyrine disposition.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; L J Moschitto; R B Smith; R I Shader
Journal:  Arch Gen Psychiatry       Date:  1983-03

9.  Acetaminophen kinetics in the elderly.

Authors:  M Divoll; D R Abernethy; B Ameer; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1982-02       Impact factor: 6.875

10.  Desmethyldiazepam kinetics in the elderly after oral prazepam.

Authors:  M D Allen; D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

View more
  7 in total

Review 1.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

2.  Acetaminophen pharmacokinetics in women receiving conjugated estrogen.

Authors:  J M Scavone; D J Greenblatt; G T Blyden; B G Luna; J S Harmatz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Effect of antipyrine coadministration on the kinetics of acetaminophen and lidocaine.

Authors:  G T Blyden; D J Greenblatt; B W LeDuc; J M Scavone
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Single dose oxazepam has no effect on acetaminophen clearance or metabolism.

Authors:  J Sonne; H E Poulsen; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Co-regulation of phenytoin and tolbutamide metabolism in humans.

Authors:  W Tassaneeyakul; M E Veronese; D J Birkett; C J Doecke; M E McManus; L N Sansom; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

6.  Covariates of intravenous paracetamol pharmacokinetics in adults.

Authors:  Karel Allegaert; Klaus T Olkkola; Katie H Owens; Marc Van de Velde; Monique M de Maat; Brian J Anderson
Journal:  BMC Anesthesiol       Date:  2014-09-13       Impact factor: 2.217

Review 7.  Paracetamol in Older People: Towards Evidence-Based Dosing?

Authors:  Paola Mian; Karel Allegaert; Isabel Spriet; Dick Tibboel; Mirko Petrovic
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.